Joshua Raoul Lindner

Mr. Joshua Raoul Lindner


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MFMargaux Fresnais
Margaux Fresnais
SLSiwen Liang
Siwen Liang
MBMarius Breitkopf
Marius Breitkopf
JLJoshua Raoul Lindner
Joshua Raoul Lindner
ECEmmanuelle Claude
Emmanuelle Claude
Rémi LonguespéeRémi Longuespée
Rémi Longuespée
Desorption/ionization (DI)-mass spectrometric (MS) methods offer considerable advantages of rapidity and low-sample input for the analysis of solid biological matrices such as tissue sections. The concept of desorption electrospray ionization (DESI) offers the possibility to ionize compounds from solid surfaces at atmospheric pressure, without the addition of organic compounds to initiate desorption. However, severe drawbacks from former DESI hardware stability made the development of assays for drug quantification difficult. In the present study, the potential of new prototype source setups (High Performance DESI Sprayer and Heated Transfer Line) for the development of drug quantification assays in tissue sections was evaluated. It was demonstrated that following dedicated optimization, new DESI XS enhancements present promising options regarding targeted quantitative analyses. As a model compound for these developments, ulixertinib, an inhibitor of extracellular signal-regulated kinase (ERK) 1 and 2 was used.

21 December 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
MFMargaux Fresnais
Margaux Fresnais
Sevin TurcanSevin Turcan
Sevin Turcan
DTDirk Theile
Dirk Theile
JUJohannes Ungermann
Johannes Ungermann
YZYasmin Abou Zeed
Yasmin Abou Zeed
Rémi LonguespéeRémi Longuespée
Rémi Longuespée
Temozolomide (TMZ), together with bulk resection and focal radiotherapy, is currently a standard of care for glioblastoma. Absorption, distribution, metabolism, and excretion (ADME) parameters, together with the mode of action of TMZ, make its biochemical and biological action difficult to understand. Accurate understanding of the mode of action of TMZ and the monitoring of TMZ at its anatomical, cellular, and molecular sites of action (SOAs) would greatly benefit precision medicine and the development of novel therapeutic approaches in combination with TMZ. In the present perspective article, we summarize the known ADME parameters and modes of action of TMZ, and we review the possible methodological options to monitor TMZ at its SOAs. We focus our descriptions of methodologies on mass spectrometry-based approaches, and all related considerations are taken into account regarding the avoidance of artifacts in mass spectrometric analysis during sampling, sample preparation, and the evaluation of results. Finally, we provide an overview of potential applications for precision medicine and drug development.